The Fòs Feminista data index grades government agencies on policies and funding impacting family planning, maternal and child health, and HIV & AIDS foreign assistance.
Selecting a document will download the file
2022_CDC Center for Global Health 2022 Annual Report_Making an impact through global partnershipsThis Document summarized the efforts of the CDC to advance health security globally over the last 75 years. The action was not completely responsive to need. Despite the stated commitment to health security, the Document never mentioned SRHR, which is a core component of achieving health security. The Document did not explicitly align with the human rights framework, and instead argued for improving core public health capabilities and health systems globally as a means to ensuring health security nationally. Nevertheless, the action included clear, forward-looking commitments from the Center for Global Health (CGH) to advance health equity, innovate, and adapt interventions for infectious disease including HIV. The proposed programs were based in evidence and emphasized community ownership and data-led decision making. The action moderately promoted SRHR in the HIV and AIDS domain.
2022_CDC Core Health Equity Science and Intervention StrategyThis agency-wide strategy aimed to integrate health equity across HHS. It was aligned to human rights principles, responsive to need, and based in evidence. It noted socio-economic and structural barriers to health equity, and acknowledged various populations that are often marginalized in the discussion on health. Specifically, it stated that the “CDC is transforming its public health research, surveillance, and implementation science efforts to shift from simply listing the markers of health inequities to identifying and addressing the drivers of these disparities.” Because of the strength of this detail, this action moderately promoted SRHR in the HIV and AIDS domain.
2022_General Terms and Conditions Non-Research Grant and Cooperative Agreements_revised November 2022The General Terms and Conditions listed the federal regulations and policies, funding restrictions and limitations, and reporting requirements that applied to HHS non-research grants and cooperative agreements. The action provided guidance about regular financial and performance reporting, requirements for a data management plan, audit requirements, key personnel guidelines, guidance for acknowledgement of federal funding, and CDC staff responsibilities for award management. Though this action was revised in November 2022, there was no mention of changes from the previous version. Prior versions were not available on the website for comparison, which did not promote
transparency and was not responsive to need. This action neither promoted nor hindered SRHR in the HIV and AIDS domain.
2022_General Terms and Conditions Research Grant and Cooperative Agreements_Revised November 2022The action listed the federal regulations and policies, funding restrictions and limitations, and reporting requirements that applied to HHS research grants and cooperative agreements. It provided guidance about regular financial and performance reporting, requirements for a data management plan, audit requirements, key personnel guidelines, guidance for acknowledgement of federal funding, and CDC staff responsibilities for award management. The action defined human subjects and confidentiality requirements in alignment with human rights norms and research ethics. This action was responsive to need because it provided guidance about how awards should be managed, though there was no indication of which information had been changed from the previous version. Prior versions were not available on the website for comparison, which did not promote
transparency. This action neither hindered nor promoted SRHR in the HIV and AIDS domain.
2022_CDC Global Health Equity StrategyThe action documented CDC commitments to health equity science and an intervention-based strategy to holistically reimagine how the CDC approaches health equity. It was grounded in human-rights principles and responsive to need. It clearly articulated cross-cutting principles of community engagement, inclusion strategies for the most at-risk, and a process for evidence-led decision-making. Though the action did not mention SRHR as a core goal or focus area, “addressing and managing HIV and AIDS” was included as a program specific goal with clear domestic and international commitments, indicators, and milestones. The interventions proposed for HIV addressed infrastructure and systems as well as stigma reduction related to HIV, which was based on most recent evidence. This action significantly promoted SRHR in the HIV and AIDS domain.
2022_National Strategy for Combatting Multi-drug Resistant TuberculosisThis Document reported efforts to combat tuberculosis (TB) since the launch of the USG Five Year National Strategy for Combating Multidrug Resistant Tuberculosis. The Document emphasized the impact of the COVID-19 pandemic on recent progress toward elimination and framed the rationale for addressing TB from a global health security lens rather than a human rights lens. The Document was based in evidence and committed to funding new research efforts and developing new evidence on potential interventions. While the Document mentioned several activities involving people living with HIV (PLHIV), there was no mention of integration of HIV and TB services, and no mention of PEPFAR. The Document was
gender blind, as it did not mention gender disaggregated data on prevalence, identification, and treatment or the need for gender-sensitive interventions. This Document moderately hindered SRHR in the HIV and AIDS domain.
2022_HHS Strategic Plan 2022-2026This action updated the HHS Strategic Plan, and provided priorities, accomplishments, and next steps to track HHS work. The action was responsive to need, but it did not include SRHR and gender in its Objectives and Goals, which contributes to the perceived separation of SRHR from other global health issues. As a result, it was not based in human rights or evidence. Additionally, it was not entirely responsive to the latest global data. For instance, the discussion on tuberculosis in Strategic Goal 2, Objective 2.2 could have included mention of HIV and interventions to address comorbidities. Similarly, in Strategic Goal 2, Objective 2.4 the discussion on climate change could have included its impacts on SRHR. However, some sections of the strategy committed to evidence generation through locally-led, participatory approaches. Activities to foster collaborations between the USG and international community based organizations (CBOs) to advance public health outcomes were included. This action neither promoted nor hindered SRHR in the HIV and AIDS domain.
2022_Strengthening Health Security Across the Globe: Progress and Impact of U.S. Government Investments in the Global Health Security AgendaThe action documented the United States government (USG) strategy for global health security with an emphasis on the following four areas: (1) marshaling political will, (2) developing global norms around quality of care and technical standards, (3) enhancing sustainable multilateral financing, and (4) strengthening capacities in partner countries. While the action was not explicitly based in human rights principles, it aligned to International Health Regulations, the Biological and Toxins Weapon Convention, United Nations (UN) Security Council Resolution 1540, and other international health conventions that are rights-based. It was responsive to need and based in evidence. The action was
gender blind as it focused on supply-side interventions and did not mention gender. Despite acknowledging the work of the President's Emergency Plan for AIDS Relief (PEPFAR) globally, there was no substantive discussion about their work in health security. The action neither advanced nor hindered SRHR in the HIV and AIDS domain.
